REGENERON is trading at 83.00 as of the 4th of December 2024, a 1.5% down since the beginning of the trading day. The bond's open price was 84.26. REGENERON has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for REGENERON PHARMACEUTICALS INC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of September 2024 and ending today, the 4th of December 2024. Click here to learn more.
Our tools can tell you how much better you can do entering a position in REGENERON without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run CEOs Directory Now
CEOs Directory
Screen CEOs from public companies around the world
REGENERON financial ratios help investors to determine whether REGENERON Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in REGENERON with respect to the benefits of owning REGENERON security.